Drug Profile
Research programme: biodefence vaccines - ViRexx
Alternative Names: Biodefense vaccines - ViRexx; WEEV vaccines - ViRexx; Western equine encephalitis vaccines - ViRexxLatest Information Update: 02 Mar 2010
Price :
$50
*
At a glance
- Originator ViRexx Medical Corp
- Developer Defence Research and Development Canada; Paladin Labs
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Western equine encephalitis virus infections
Most Recent Events
- 23 Dec 2008 ViRexx Medical Corp has been acquired and merged into Paladin Labs
- 25 May 2008 Preclinical development is ongoing in Western equine encephalitis virus infections in Canada
- 13 Apr 2006 Preclinical trials in Viral infections in USA (unspecified route)